
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18102453
[patent_doc_number] => 11542328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Therapeutic and diagnostic methods relating to cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 16/435929
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 28
[patent_no_of_words] => 31881
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435929 | Therapeutic and diagnostic methods relating to cancer stem cells | Jun 9, 2019 | Issued |
Array
(
[id] => 18102453
[patent_doc_number] => 11542328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Therapeutic and diagnostic methods relating to cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 16/435929
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 28
[patent_no_of_words] => 31881
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435929 | Therapeutic and diagnostic methods relating to cancer stem cells | Jun 9, 2019 | Issued |
Array
(
[id] => 16962937
[patent_doc_number] => 20210214436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON
[patent_app_type] => utility
[patent_app_number] => 17/058335
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -122
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058335
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058335 | MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON | May 27, 2019 | Abandoned |
Array
(
[id] => 15499053
[patent_doc_number] => 20200049715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => Method of Detecting Cancer
[patent_app_type] => utility
[patent_app_number] => 16/417042
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16417042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/417042 | Method of detecting cancer | May 19, 2019 | Issued |
Array
(
[id] => 15711247
[patent_doc_number] => 20200102389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => ANTI-HLA-G ANTIBODIES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/415979
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415979 | Anti-HLA-G antibodies and use thereof | May 16, 2019 | Issued |
Array
(
[id] => 17022324
[patent_doc_number] => 20210246195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHODS OF ISOLATING ALLERGEN-SPECIFIC ANTIBODIES FROM HUMANS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/056384
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056384 | Methods of isolating allergen-specific antibodies from humans and uses thereof | May 16, 2019 | Issued |
Array
(
[id] => 16778074
[patent_doc_number] => 20210115152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => COMPOSITION OF BISPECIFIC ANTIBODIES AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/055561
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055561
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055561 | COMPOSITION OF BISPECIFIC ANTIBODIES AND METHOD OF USE THEREOF | May 14, 2019 | Pending |
Array
(
[id] => 14993749
[patent_doc_number] => 20190315832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/413192
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16413192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/413192 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | May 14, 2019 | Issued |
Array
(
[id] => 15008517
[patent_doc_number] => 10450374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Anti-galectin-9 antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/406713
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 64
[patent_no_of_words] => 93743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/406713 | Anti-galectin-9 antibodies and uses thereof | May 7, 2019 | Issued |
Array
(
[id] => 19411776
[patent_doc_number] => 12077583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Antibodies specific to human NECTIN4
[patent_app_type] => utility
[patent_app_number] => 17/052960
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 22136
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052960 | Antibodies specific to human NECTIN4 | May 5, 2019 | Issued |
Array
(
[id] => 17241962
[patent_doc_number] => 20210361705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => REPROGRAMMING CD4 T CELLS INTO CYTOTOXIC CD8 CELLS BY FORCED EXPRESSION OF CD8aB AND CLASS 1 RESTRICTED T CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/048490
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048490 | Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab and class 1 restricted t cell receptors | Apr 17, 2019 | Issued |
Array
(
[id] => 14993823
[patent_doc_number] => 20190315869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => METHODS FOR TREATING CANCER IN PATIENTS WITH ELEVATED LEVELS OF BIM
[patent_app_type] => utility
[patent_app_number] => 16/384313
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384313 | Methods for treating cancer in patients with elevated levels of Bim | Apr 14, 2019 | Issued |
Array
(
[id] => 15524839
[patent_doc_number] => 20200054725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => BREAST AND OVARIAN CANCER VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/370683
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370683 | Breast and ovarian cancer vaccines | Mar 28, 2019 | Issued |
Array
(
[id] => 16793007
[patent_doc_number] => 20210122824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ANTI-PD-L1 ANTIBODIES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/043454
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043454 | Anti-PD-L1 antibodies and use thereof | Mar 28, 2019 | Issued |
Array
(
[id] => 18202406
[patent_doc_number] => 11584788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
[patent_app_type] => utility
[patent_app_number] => 16/365978
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 43
[patent_no_of_words] => 58297
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365978 | Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms | Mar 26, 2019 | Issued |
Array
(
[id] => 19955330
[patent_doc_number] => 12325737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-10
[patent_title] => Total afucosylated glycoforms of antibodies produced in cell culture
[patent_app_type] => utility
[patent_app_number] => 17/040422
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 17354
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040422 | Total afucosylated glycoforms of antibodies produced in cell culture | Mar 25, 2019 | Issued |
Array
(
[id] => 16583101
[patent_doc_number] => 20210017503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC
[patent_app_type] => utility
[patent_app_number] => 16/981626
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981626 | BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC | Mar 17, 2019 | Abandoned |
Array
(
[id] => 16570705
[patent_doc_number] => 20210009711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => MULTIFUNCTIONAL MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/980771
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -134
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980771
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980771 | MULTIFUNCTIONAL MOLECULES AND USES THEREOF | Mar 13, 2019 | Abandoned |
Array
(
[id] => 17149511
[patent_doc_number] => 11142574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Anti-TIM-3 antibodies
[patent_app_type] => utility
[patent_app_number] => 16/294474
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 17
[patent_no_of_words] => 20103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/294474 | Anti-TIM-3 antibodies | Mar 5, 2019 | Issued |
Array
(
[id] => 17541040
[patent_doc_number] => 11306151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Anti-TIP-1 antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/733554
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10129
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733554 | Anti-TIP-1 antibodies and uses thereof | Mar 5, 2019 | Issued |